SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-211924
Filing Date
2018-07-03
Accepted
2018-07-03 07:31:00
Documents
5
Period of Report
2018-07-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d674537d8k.htm 8-K 29794
2 EX-2.1 d674537dex21.htm EX-2.1 471635
3 EX-3.1 d674537dex31.htm EX-3.1 4226
4 EX-99.1 d674537dex991.htm EX-99.1 14604
5 GRAPHIC g674537g56h68.jpg GRAPHIC 4315
  Complete submission text file 0001193125-18-211924.txt   527701
Mailing Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110
Business Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110 617-639-1500
JUNIPER PHARMACEUTICALS INC (Filer) CIK: 0000821995 (see all company filings)

IRS No.: 592758596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10352 | Film No.: 18934703
SIC: 2834 Pharmaceutical Preparations